Back to today’s briefing

Story perspectives

Semaglutide Cuts Alcohol Cravings by 40%, Offers Hope

2/15/2025

28 6

Summary

Story summary

A groundbreaking study in JAMA Psychiatry reveals that semaglutide, a GLP-1 receptor agonist, can dramatically curb alcohol cravings and consumption. Participants experienced a staggering 40% reduction in alcohol intake over nine weeks. This promising finding offers hope for the 28 million Americans battling alcohol use disorder, positioning semaglutide as a potential game-changer in treatment.

1 of 1

Story summary

A groundbreaking study in JAMA Psychiatry reveals that semaglutide, a GLP-1 receptor agonist, can dramatically curb alcohol cravings and consumption. Participants experienced a staggering 40% reduction in alcohol intake over nine weeks. This promising finding offers hope for the 28 million Americans battling alcohol use disorder, positioning semaglutide as a potential game-changer in treatment.